Nuclear medicine is moving fast, with exciting new science and real potential to change patient care but turning that promise into approved therapies is still far from straightforward. This plenary will explore why strong programs so often get stuck between discovery and the clinic, and how clearer thinking around funding, regulation, and business development can help teams navigate the complexity and move forward with confidence.